Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pais

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Change Detection in Electrocardiogram (ECG) Signals After Postoperative Pain ManagementDaniela Pais, Raquel Sebastiao, Susana Bras
Science Immunology|November 17, 2023
Emergence and fate of stem cell-like <i>Tcf7</i><sup>+</sup> CD8<sup>+</sup> T cells during a primary immune response to viral infectionJoana Gomes Silva, Daniela Pais Ferreira, Alexandre Dumez, et al.
Trauma Case Reports|March 5, 2021
Hemoperitoneum secondary to mesenteric laceration after abdominal trauma - Case reportMarta M Ferreira, Narcisa Guimarães, Inês Bolais Mónica, et al.
Immunity|August 18, 2016
T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral InfectionsDaniel T Utzschneider, Mélanie Charmoy, Vijaykumar Chennupati, et al.
Immunity|January 13, 2019
Intratumoral Tcf1<sup>+</sup>PD-1<sup>+</sup>CD8<sup>+</sup> T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade ImmunotherapyImran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity|October 31, 2020
Central memory CD8<sup>+</sup> T cells derive from stem-like Tcf7<sup>hi</sup> effector cells in the absence of cytotoxic differentiationDaniela Pais Ferreira, Joana Gomes Silva, Tania Wyss, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.
Blood|May 16, 2023
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myelomaBlandine Pouleau, Carole Estoppey, Perrine Suere, et al.
Nature Cancer|September 11, 2024
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cellsLaura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Change Detection in Electrocardiogram (ECG) Signals After Postoperative Pain ManagementDaniela Pais, Raquel Sebastiao, Susana Bras
Science Immunology|November 17, 2023
Emergence and fate of stem cell-like <i>Tcf7</i><sup>+</sup> CD8<sup>+</sup> T cells during a primary immune response to viral infectionJoana Gomes Silva, Daniela Pais Ferreira, Alexandre Dumez, et al.
Trauma Case Reports|March 5, 2021
Hemoperitoneum secondary to mesenteric laceration after abdominal trauma - Case reportMarta M Ferreira, Narcisa Guimarães, Inês Bolais Mónica, et al.
Immunity|August 18, 2016
T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral InfectionsDaniel T Utzschneider, Mélanie Charmoy, Vijaykumar Chennupati, et al.
Immunity|January 13, 2019
Intratumoral Tcf1<sup>+</sup>PD-1<sup>+</sup>CD8<sup>+</sup> T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade ImmunotherapyImran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity|October 31, 2020
Central memory CD8<sup>+</sup> T cells derive from stem-like Tcf7<sup>hi</sup> effector cells in the absence of cytotoxic differentiationDaniela Pais Ferreira, Joana Gomes Silva, Tania Wyss, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.
Blood|May 16, 2023
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myelomaBlandine Pouleau, Carole Estoppey, Perrine Suere, et al.
Nature Cancer|September 11, 2024
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cellsLaura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, et al.
Pageof 1